COMP <GO>
HNGE vs MSFT // FREE CASH FLOW YIELD
Hinge Health Inc. (NYSE) VS. Microsoft Corporation (NASDAQ) • 15-METRIC TALLY: HNGE 7
— MSFT 7
▲ FREE CASH FLOW YIELD LEADER: HNGE
LAST: $114.32 (-2.21%) • MKT CAP: $9.43B
fcf-yield
1.81%
LAST: $521.91 (-1.55%) • MKT CAP: $3.88T
fcf-yield
1.55%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HNGE VS. MSFT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HNGE | MSFT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 67.66% | +11.94 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 26.54% | -61.54 | MSFT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 19.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 1.81% | 1.55% | +0.26 | HNGE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 47.10% | -107.10 | MSFT | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 41.17% | -101.17 | MSFT | /net-margins <GO> |
| Revenue Growth (YoY) | 50.60% | 17.91% | +32.69 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.70% | -0.70 | MSFT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.12 | 9.35 | +2.77 | HNGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | HNGE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.70% | 5.74% | +1.96 | MSFT | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 49.0 | +18.48 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.14 | +0.10 | HNGE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 24.2x | +4.81 | MSFT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.43B | $3.88T | -$3.87T | MSFT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HNGE REV | MSFT REV | HNGE GROSS % | MSFT GROSS % | HNGE FCF | MSFT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $331.84B | — | 67.9% | — | $66.99B |
| FY 2025 | $587.9M | $281.72B | 79.6% | 68.8% | $170.7M | $71.61B |
| FY 2024 | $390.4M | $245.12B | 76.8% | 69.8% | $48.0M | $74.07B |
| FY 2023 | $292.7M | $211.91B | 44.0% | 68.9% | -$77.1M | $59.48B |
| FY 2022 | — | $198.27B | — | 68.4% | — | $65.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HNGE // BETA 1.24
MSFT // BETA 1.14